Summary
Court finds plaintiff expert’s lost profits calculation regarding two-supplier market is inadmissible and rejects reasonable royalty to the extent expert failed to explain how apportionment in benchmark licenses relates to expert’s hypothetical license.
Bio Rad Labs v. 10X Genomics Inc2
PDF, Size: 88 KB
See Also
Daubert Ruling on How to Satisfy Apportionment When Using Benchmark Licenses
Court finds plaintiff expert’s lost profits calculation regarding two-supplier market is inadmissible and rejects reasonable royalty to the extent expert failed to explain how apportionment in benchmark licenses relates to expert’s hypothetical license.